High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division

Nature Immunology

Volumn 5, Issue 1, 2004, Pages 31-37

  Veiga Fernandes, Henrique ^a   Rocha, Benedita ^a  

^a Institut Necker   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; ENZYME INHIBITOR; PROTEIN P27; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIVISION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; CYTOPLASM; FEMALE; FLOW CYTOMETRY; G1 PHASE; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, PHASE-CONTRAST; TUMOR SUPPRESSOR PROTEINS;

EID: 0346496026     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1015     Document Type: Article

References (29)

1. Freitas, A.A. & Rocha, B. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18, 83-111 (2000).
2. + T cell memory. Immunol. Rev. 150, 23-44 (1996).
3. Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996).
4. Sprent, J., Tough, D.F. & Sun, S. Factors controlling the turnover of T memory cells. Immunol. Rev. 156, 79-85 (1997).
5. + T cells in an in vivo response. J. Immunol. 155, 3719-3721 (1995).
6. + T cells to antigen stimulation in vivo. Nat. Immunol. 1, 47-53 (2000).
7. Sherr, C.J. Mammalian G1 cyclins. Cell 73, 1059-1065 (1993).
8. Sherr, C.J. & Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
9. Sherr, C.J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689-3695 (2000).
10. Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272, 25863-25872 (1997).
11. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J. 18, 1571-1583 (1999).
12. LaBaer, J. et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862 (1997).
13. Parry, D., Mahony, D., Wills, K. & Lees, E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19, 1775-1783 (1999).
14. Soos, T.J. et al. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7, 135-146 (1996).
15. Tanchot, C., Lemonnier, F.A., Perarnau, B., Freitas, A.A. & Rocha, B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276, 2057-2062 (1997).
16. Olashaw, N. & Pledger, W.J. Paradigms of growth control: relation to cdk activation. Sci. STKE 2002, Re7 (2002).
17. kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6, 290-297 (2000).
18. Kip1 regulates T cell proliferation. J. Biol. Chem. 276, 21976-21983 (2001).
19. Kitagawa, M. et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. Embo J. 15, 7060-7069 (1996).
20. INK4c is required for the generation of functional plasma cells. Immunity 17, 179-189 (2002).
21. INK4c and IL-6. Immunity 6, 47-56 (1997).
22. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662 (1995).
23. Balomenos, D. et al. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6, 171-176 (2000).
24. Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027 (1995).
25. Pines, J. & Hunter, T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. Embo J. 13, 3772-3781 (1994).
26. Dickens, M. et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693-696 (1997).
27. Kip1. Cell 85, 721-732 (1996).
28. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720 (1996).
29. Kip1-deficient mice. Cell 85, 733-744 (1996).